Press-release for stocks for abbvie inc. for CMXHF

| -6.21% | O: -0.64% H: 0.54% C: 0.54%
GLAXF | $20.2 -14.18% 510

| 3.11% | O: -0.56% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| -10.78% | O: -1.83% H: 0.0% C: 0.0%
ALPMY | $9.46 -1.11% 500K

| -22.81% | O: -1.74% H: 0.0% C: -1.35%
NVS | $92.57 -0.55% 0.0% 910K

| -13.57% | O: 0.49% H: 0.18% C: 0.04%
GSK | $39.27 -0.83% 0.01% 2.2M

| -0.7% | O: -0.08% H: 0.1% C: -0.18%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 1.95% | O: -0.15% H: 0.74% C: 0.18%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -11.92% | O: 0.45% H: 0.06% C: -0.5%
america therapeutics market

Orphan drugs market to grow by USD 170.8 billion between 2022 and 2027; Growth driven by rising incidence of rare diseases - Technavio
Published: 2023-05-03 (Crawled : 01:00) - prnewswire.com
CSLLY | $87.96 3.3% 45K

| -12.47% | O: -0.56% H: 0.36% C: -0.28%
AZNCF | $140.15 -4.19% 560

| -7.42% | O: 3.52% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| 10.16% | O: -1.96% H: 0.0% C: 0.0%
ALPMY | $9.46 -1.11% 500K

| -38.02% | O: 1.86% H: 0.0% C: -0.65%
NVS | $92.57 -0.55% 0.0% 910K

| -10.1% | O: 0.55% H: 0.68% C: 0.33%
GSK | $39.27 -0.83% 0.01% 2.2M

| 8.94% | O: 1.24% H: 1.14% C: 0.11%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 8.93% | O: -0.36% H: 0.29% C: -1.2%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -14.78% | O: 0.71% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| -7.37% | O: 0.75% H: 0.98% C: 0.46%
rare growth market

Global Bioengineered Protein Drugs Markets Report 2023: A $521.3 Billion Market by 2027 Featuring AbbVie, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Merck and Sanofi
Published: 2023-04-20 (Crawled : 01:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -12.72% | O: -1.07% H: 1.56% C: -0.01%
CSLLY | $87.96 3.3% 45K

| -12.73% | O: 0.23% H: 0.39% C: -0.18%
GLAXF | $20.2 -14.18% 510

| 9.19% | O: -0.08% H: 0.0% C: -0.68%
AZNCF | $140.15 -4.19% 560

| -8.44% | O: 0.42% H: 0.0% C: -0.53%
NVSEF | $93.6375 6.88% 82K

| 14.66% | O: 0.61% H: 0.0% C: 0.0%
NVO | $122.75 -1.43% 0.0% 2.8M

| -24.54% | O: 0.33% H: 0.36% C: -0.13%
NVS | $92.57 -0.55% 0.0% 910K

| -5.04% | O: 0.34% H: 0.28% C: 0.25%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -10.82% | O: -0.06% H: 0.86% C: 0.71%
GSK | $39.27 -0.83% 0.01% 2.2M

| 7.23% | O: -0.24% H: 0.0% C: -1.03%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 2.45% | O: -0.02% H: 0.37% C: 0.35%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -18.24% | O: -0.03% H: 0.0% C: 0.0%
BNTX | $86.19 -0.24% -0.24% 580K

| -29.25% | O: -0.85% H: 1.51% C: 0.15%
AZN | $68.36 -0.25% -0.25% 4M

| -8.79% | O: 0.05% H: 0.11% C: -0.47%
AMGN | $262.77 -0.49% -0.49% 2M

| 7.61% | O: -0.04% H: 0.11% C: -1.08%
ADMA 4 | $6.21 2.82% 2.74% 3M

| 79.19% | O: -0.87% H: 1.17% C: 0.29%
report merck global protein sanofi market

Women's Health Therapeutics Market size to grow at a CAGR of 5.74% from 2021 to 2026, Growth Driven by Strategic Alliances - Technavio
Published: 2023-04-13 (Crawled : 02:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -12.06% | O: 2.76% H: 0.0% C: -0.26%
CSLLY | $87.96 3.3% 45K

| -13.34% | O: 0.44% H: 0.83% C: 0.51%
SNYNF | News | $92.7 -2.18% 1.4K

| -18.15% | O: -1.1% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| 16.68% | O: 1.25% H: 0.51% C: 0.51%
NVS | $92.57 -0.55% 0.0% 910K

| -3.51% | O: 1.3% H: 0.56% C: 0.51%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 1.72% | O: -0.84% H: 1.16% C: 1.05%
ABT | News | $105.27 -0.6% -0.15% 7.3M

| 3.74% | O: 0.19% H: 0.93% C: 0.84%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -18.62% | O: 0.29% H: 0.0% C: 0.0%
ICLR | $291.74 -0.1% -0.1% 500K

| 40.01% | O: 0.35% H: 1.1% C: 0.47%
AMGN | $262.77 -0.49% -0.49% 2M

| 6.19% | O: -0.36% H: 1.33% C: 1.14%
health therapeutics growth market

Plasma Protease C1 Inhibitor Market size to grow by USD 1.7 billion from 2021 to 2026, Driven by the increasing R&D - Technavio
Published: 2023-04-12 (Crawled : 09:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -12.23% | O: -0.19% H: 0.0% C: 0.0%
CSLLY | $87.96 3.3% 45K

| -12.71% | O: 1.43% H: 0.0% C: -0.7%
GLAXF | $20.2 -14.18% 510

| 8.02% | O: 1.63% H: 0.0% C: -2.39%
NVSEF | $93.6375 6.88% 82K

| 17.97% | O: 1.1% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K

| -2.84% | O: 0.75% H: 0.5% C: -0.05%
GSK | $39.27 -0.83% 0.01% 2.2M

| 6.02% | O: 1.15% H: 0.39% C: -0.19%
BHC | $8.6 -0.69% 0.0% 2.1M

| 14.7% | O: 1.31% H: 0.26% C: -4.4%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 2.34% | O: 0.46% H: 0.84% C: 0.15%
KALV | $11.53 -1.03% -1.04% 410K

| 37.54% | O: 0.71% H: 0.0% C: -6.45%
ARGX | $358.65 -2.06% -2.11% 240K

| -1.1% | O: 1.26% H: 0.48% C: 0.04%
market

Antimicrobial Therapeutics Market size to grow by USD 51.4 billion from 2022 to 2027, Driven by initiatives from government agencies in the pharmaceutical industry - Technavio
Published: 2023-04-11 (Crawled : 02:00) - prnewswire.com
CSLLY | $87.96 3.3% 45K

| -12.35% | O: 0.09% H: 0.39% C: 0.33%
GLAXF | $20.2 -14.18% 510

| 6.46% | O: -0.69% H: 0.0% C: -0.77%
SNYNF | News | $92.7 -2.18% 1.4K

| -16.98% | O: -1.75% H: 0.0% C: 0.0%
ALPMY | $9.46 -1.11% 500K

| -35.14% | O: -1.74% H: 0.0% C: -0.71%
NVS | $92.57 -0.55% 0.0% 910K

| -2.74% | O: 0.02% H: 0.62% C: 0.08%
GSK | $39.27 -0.83% 0.01% 2.2M

| 4.57% | O: -0.11% H: 0.0% C: -1.27%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 2.41% | O: 0.13% H: 0.68% C: -0.07%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -17.91% | O: 0.4% H: 0.0% C: 0.0%
therapeutics market

Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $262.77 -0.49% -0.49% 2M

| Email alert Add to watchlist
CSLLY | $87.96 3.3% 45K

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
MNKPF | $17.25

| Email alert Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M

| Email alert Add to watchlist
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
ALPMY | $9.46 -1.11% 500K

| Email alert Add to watchlist
VTRS | $11.11 0.09% 0.09% 3.5M

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
UCBJY | $64.07 -4.38% 72K

| Email alert Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K

| Email alert Add to watchlist
ALPMF | $9.594 43.47% 2.2K

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K

| Email alert Add to watchlist
BHC | $8.6 -0.69% 0.0% 2.1M

| Email alert Add to watchlist
UCBJF | $126.05 -39.66% 100

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
ENDPQ | $0.0006 -50.0% 620K

| Email alert Add to watchlist
CMXHF | $172.54 -19.21% 50

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M

| Email alert Add to watchlist
MNKKQ | $0.02

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M

| Email alert Add to watchlist
NVO | $122.75 -1.43% 0.0% 2.8M

| Email alert Add to watchlist
global report

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -10.86% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $87.96 3.3% 45K

| -11.33% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | $140.15 -4.19% 560

| 3.92% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $541.52 -1.05% 0.61% 2.1M

| -4.57% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $12.78 -3.03% -0.24% 9M

| 33.0% | O: -1.21% H: 0.43% C: -3.58%
TAK | News | $13.16 0.08% 0.0% 1.3M

| -15.92% | O: 0.83% H: 0.06% C: -1.2%
PRGO | $29.94 -0.33% 0.0% 970K

| -18.72% | O: 0.76% H: 1.91% C: 1.26%
GSK | $39.27 -0.83% 0.01% 2.2M

| 14.95% | O: 0.32% H: 0.17% C: -1.53%
LLY | $745.95 -0.64% -0.1% 1.7M

| 135.38% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $55.8 -0.29% 0.0% 1M

| -21.81% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.3 0.96% -0.1% 11M

| -29.9% | O: 0.41% H: 0.04% C: -1.71%
ALB | News | $111.8 -2.26% 0.63% 2.2M

Process Industries

| -55.43% | O: -0.95% H: 1.02% C: -2.19%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 6.36% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -4.65% | O: 0.65% H: 0.0% C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M

| -17.52% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $190.55 -0.84% -0.84% 1.5M

| -27.79% | O: 0.28% H: 0.0% C: -2.26%
AZN | $68.36 -0.25% -0.25% 4M

| 5.74% | O: 0.9% H: 0.28% C: -1.3%
global report market

Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K

| -94.35% | O: -1.13% H: 28.57% C: 19.0%
CSLLY | $87.96 3.3% 45K

| -9.95% | O: -3.93% H: 2.17% C: 1.75%
MNK | $0.3402 -0.06% 540K

| -94.75% | O: 3.1% H: 0.0% C: -2.75%
GLAXF | $20.2 -14.18% 510

| 15.53% | O: -0.2% H: 2.06% C: 2.06%
SNYNF | News | $92.7 -2.18% 1.4K

| -3.71% | O: 1.09% H: 0.54% C: 0.54%
UCBJY | $64.07 -4.38% 72K

| 63.03% | O: 1.0% H: 0.0% C: -0.26%
ALPMY | $9.46 -1.11% 500K

| -38.39% | O: 3.43% H: 0.0% C: -2.93%
VTRS | $11.11 0.09% 0.09% 3.5M

| -0.09% | O: 0.54% H: 2.5% C: 1.7%
NVO | $122.75 -1.43% 0.0% 2.8M

| -7.99% | O: 1.43% H: 0.84% C: -0.23%
NVS | $92.57 -0.55% 0.0% 910K

| 2.6% | O: 0.42% H: 1.35% C: 1.22%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -17.95% | O: -0.28% H: 1.26% C: 1.15%
GSK | $39.27 -0.83% 0.01% 2.2M

| 12.69% | O: -0.57% H: 1.35% C: 1.0%
BHC | $8.6 -0.69% 0.0% 2.1M

| 39.17% | O: 0.48% H: 3.96% C: -0.48%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 2.2% | O: 0.27% H: 0.6% C: 0.21%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -5.89% | O: 0.16% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M

| 0.87% | O: -0.67% H: 0.66% C: 0.3%
pharma global market

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M

Commercial Services

INVO | $1.555 104.6% 51.13% 5M

Professional, Scientific, and T...

ISPC | $0.437 105.16% 49.53% 37M

WLGS | News | $0.92 84.0% 45.65% 1.6M

OST | $0.499 21.38% 45.26% 1.9M

XPON | News | $3.1 60.62% 37.74% 17M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | News | $6.92 44.17% 30.64% 3.5M